Switching to adjuvant exemestane after tamoxifen improves disease-free survival in postmenopausal women with hormone receptor-positive early breast cancer

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.5, 2007-05, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Physical activity and survival of postmenopausal, hormone receptor–positive breast cancer patients: Results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study

By Glas Nienke A.   Fontein Duveken B. Y.   Bastiaannet Esther   Pijpe Anouk   De Craen Anton J. M.   Liefers Gerrit-Jan   Nortier Hans J. W. R.   Haes Hanneke J. C. J. M.   Velde Cornelis J. H.   Leeuwen Flora E.  

Cancer, Vol. 120, Iss. 18, 2014-09 ,pp. : 2847-2854

Blackwell Publishing

Access to resources Recommend Favorite

Adjuvant Endocrine Therapy in Hormone Receptor-Positive Postmenopausal Breast Cancer: Evolution of NCCN, ASCO, and St Gallen Recommendations

By Carlson Robert W.   Hudis Clifford A.   Pritchard Kathy I.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 10, 2006-11 ,pp. : 971-979

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Fulvestrant: A Review of its Use in Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women with Disease Progression following Antiestrogen Therapy

By McKeage K.   Curran M.P.   Plosker G.L.  

Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. : 633-648

Adis International

Access to resources Recommend Favorite

Lapatinib: In Postmenopausal Women with Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer

By Curran Monique P.  

Drugs, Vol. 70, Iss. 11, 2010-07 ,pp. : 1411-1422

Adis International

Access to resources Recommend Favorite

Tamoxifen Plus Chemotherapy versus Tamoxifen Alone as Adjuvant Therapies for Node-Positive Postmenopausal Women with Early Breast Cancer: A Stochastic Economic Evaluation

By Karnon J.   Brown J.  

PharmacoEconomics, Vol. 20, Iss. 2, 2002-02 ,pp. : 119-137

Adis International

Access to resources Recommend Favorite